You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Touchlight and 20Med partner on vaccine platform

20Med Therapeutics – a company focused on developing gene therapies and vaccines – alongside enzymatic DNA production specialists, Touchlight, have revealed that they have embarked on a vital collaboration.